|
HCV Research and Development Company a Promising Investment
According to some investor analysts, Achillion's research and development programs (including potential Hep C solutions) make this company an ideal stock purchase....
Trial Tackling Hepatitis C With New Drug
By enrolling Hepatitis C patients for whom treatment with combination therapy is not advised, Conatus Pharmaceuticals is testing a unique compound that inhibits the activity of matrix metalloproteinases....
Apple CEO Gets Hotly Debated Liver Transplant
Ever since a Tennessee hospital disclosed that an internationally known businessman - Steve Jobs - recently received a liver transplant there, controversy has swirled around transplantation fairness....
|